Study of zonisamide ( TRERIEF® tablet 25mg ) to tremor in patients with early Parkinson's disease.
Not Applicable
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000010371
- Lead Sponsor
- Department of Neurology, University of Yamanashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with Parkinsonism other than Parkinson's disease 2) Patients who have taken zonisamide 3) Patients with dementia : [Mini Mental State Examination (MMSE) score is less than 22points 4) Patients with severs disease of heart, renal, liver, and other life-threatening diseases 5) Patients who are determined as unfit for the study by attending physicians for reasons other than those stated above
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of tremor detected by actigraph
- Secondary Outcome Measures
Name Time Method The change of UPDRS Part 2,3 The change of RBDSQ-J Adverse Events